Federal Circuit’s Sleepy Obviousness Decision and Vanda’s En Banc Rehearing Petition
Patently-O
JULY 31, 2023
by Dennis Crouch Documents: FedCir Vanda Decision ; Vanda EnBanc Brief The Federal Circuit recently sided with the accused infringers Teva and Apotex, affirming the invalidation claims from four Vanda patents covering methods of using tasimelteon to treat circadian rhythm disorders. Responsive briefing from the generics are due on August 1.
Let's personalize your content